Heating Benefit Payment Changes: New Rules for 2026+

Heating Benefit Payment Changes: New Rules for 2026+

January 14, 2026 Victoria Sterling -Business Editor Business

On January 9, 2026, the President ⁤signed the Act of December 18, 2025, amending the acts to improve support mechanisms for ‍electricity and heat recipients, introducing changes to the regulations regarding a new benefit aimed⁢ at supporting heating bills for people at risk of energy poverty. The mayor,‍ town ⁣mayor or city president will be able to reject an ⁢submission for the benefit (heating allowance) without consideration⁢ (and thus -⁣ the benefit will not be⁣ paid) if the circumstances specified in the amendment occur. This applies to both applications for the benefit for 2026 and for 2025, for which the deadline for submission expired on December 15 this year.

Nowe 500 plus (a w 2026 r. – 1000 plus) na ogrzewanie, czyli bon‌ ciepłowniczy – komu przysługuje świadczenie, które ma stanowić wsparcie w‍ pokryciu kosztów wynikających z rachunków‌ za ogrzewanie?

Table of Contents

Bon ciepłowniczy, to nowe świadczenie, przysługujące na podstawie ustawy z dnia ‌12 września 2025 r. o bonie ​ciepłowniczym oraz o zmianie niektórych ustaw w celu ograniczenia wysokości cen energii elektrycznej, którego ⁤celem jest wsparcie dotyczące rachunków za ogrzewanie dla osób zagrożonych ubóstwem energetycznym. jak wynika‌ z informacji opublikowanej w dniu 29 września br. na stronie internetowej Kancelarii Prezydenta – świadczenie to ma pokryć część należności⁣ odbiorców ciepła wobec przedsiębiorstw energetycznych ⁣prowadzących działalność‌ niekoncesjonowaną i ‍koncesjonowaną ‍w zakresie wytwarzania ​i dystrybucji ciepła, ⁢wynikających ze wzrostu kosztów ogrzewania.

The Ministry of⁤ Energy explains that ⁢the energy price freeze mechanism is only valid until‍ the end of 2025 – “a return to market prices [ed.: in terms of electricity bills; starting in 2026] might potentially be significantly ‍burdensome‍ for households ‌with the lowest incomes. Consequently,it is advisable to introduce new‌ regulations implementing a protective mechanism in the form‌ of a heating allowance (…). A number of⁤ solutions contained in the draft law are modeled on proven solutions contained ⁢in the Act of May 23, 2024, on the energy allowance and amending ‍certain acts to limit the prices of electricity, natural gas and system ‍heat.”

New 500 plus (and 1000​ plus in 2026) for ‌heating, or the heating ‌allowance – how much ‍benefit can ⁢you receive, which is intended to support covering the costs resulting ⁣from heating bills?

the amount of the heating allowance depends on the price of heat.For the second half of 2025, it is a one-time payment of:

Dalszy ⁢ciąg m

Nowe​ 500​ plus⁤ (a​ w 2026 r. – 1000 plus) na ogrzewanie,‌ czyli bon‌ ciepłowniczy – w jaki‌ sposób i w jakim terminie można⁤ wnioskować do gminy/miasta o przyznanie​ świadczenia, które ma⁤ stanowić wsparcie ‌w pokryciu kosztów wynikających z rachunków za ogrzewanie?

Wnioski o wypłacę bonu ciepłowniczego ‌należy składać do wójta, burmistrza lub prezydenta miasta,⁢ właściwego⁤ ze względu‌ na‍ miejsce zamieszkania. Wnioski dotyczące:

  • okresu od 1 lipca do 31 grudnia 2025 roku – były przyjmowane ⁣od 3 listopada do 15 grudnia 2025 roku,a odpowiednio
  • okresu od 1 stycznia do 31 grudnia 2026 roku – będą przyjmowane od 1 lipca do 31 sierpnia 2026 roku.

Jeżeli wniosek o przyznanie ⁢bonu​ ciepłowniczego nie zostanie złożony w ww. terminach – świadczenie przepadnie.

W przypadku gdy wniosek o ⁣wypłatę⁤ bonu ciepłowniczego dla gospodarstwa domowego wieloosobowego złoży więcej niż jedna osoba ⁢- bon zostanie wypłacony osobie, która jako pierwsza ⁣złożyła wniosek w⁣ tym‍ gospodarstwie domowym. Pozostałe wnioski zostaną natomiast pozostawione bez rozpoznania. Ponadto, na potrzeby składania wniosków o wypłatę bonu, w⁣ ustawie przyjęto, że – jedna ⁣osoba może wchodzić w skład ‌wyłącznie‌ jednego gospodarstwa domowego, a w przypadku dwóch lub‌ więcej gospodarstw domowych

So, system heat?

system heat⁤ is heat produced in⁣ heating plants⁤ and combined heat and power plants and transmitted to buildings via district heating ⁢networks to provide heating and hot water. ‍It ‌is a way to heat buildings​ that does not require individual boilers or stoves.

That is:

  • if someone has a gas, coal, pellet stove‌ or a heat pump in their house – the heating allowance does not‌ apply to ‍them,
  • if, however, someone has radiators powered by a district heating network‍ in their house -⁤ this is ‌precisely who the allowance is intended for.

in this regard – the authorities of the Rokietnica commune in the Wielkopolska province informed it’s residents that, due to the fact ⁤that there are no heating plants or combined heat and power plants in the commune, and buildings are heated by individual stoves/heat pumps, gas or other available methods – residents of ⁣the ‍commune do not have the possibility to apply for a heating allowance: “Residents of the Rokietnica Commune do not need to submit applications for a heating ⁤allowance, as the benefit will not be due.” – we read in the dialogue⁤ issued on November 5th ‍this year.

The above means that the new benefit in the form of a heating allowance primarily concerns residents of larger cities who use heat from heating plants or combined heat and power plants, and residents of smaller towns using “own“ heating sources cannot count‍ on support to‌ cover the costs resulting from‍ heating ⁣bills.

What does this mean⁣ for applicants?

The new ⁤regulations specify that applications⁢ for the heating allowance for the period ⁣from January 1 to December 31, 2026, will be ‍accepted from ​July 1 to August 31, 2026. If an application for the benefit‌ is submitted to a municipality or city where ‌there is ​no system heating or where ‌the net single-component heat price does not ⁣exceed PLN 170/GJ net (the mayor, city president, ⁤or voivode will inform about this ⁢in advance) – it will be left unanswered.

Regarding the allowance for the period from‍ July 1 to‍ December 31,2025,for which applications could be submitted until December 15,2025 ⁤- a similar information ‌ about ​the lack of a heating‍ system in a⁢ given municipality or about the net single-component heat price not exceeding PLN 170/GJ net – ⁤ the mayor,city president,and voivode⁢ will be obliged to make public within 7 days of the entry​ into force‍ of the amendment. If applications for the payment⁣ of ⁤the bonus‍ for the period from July 1 to December 31, 2025 – were thus submitted despite the above ⁢circumstances, they will also be left unanswered.

On⁤ January‌ 9, 2026, President Karol Nawrocki signed ​the Act of December 18, 2025, amending the acts to improve the⁢ mechanisms of support for electricity and heat consumers, which introduces the above changes‌ in the rules for paying the heating allowance. The new regulations ⁢will come into force next week – on the day⁢ following the publication of the Act in the‌ Journal of Laws, which had ‍not yet ⁤happened on January 9 of this year.

As emphasized in the communication published by the​ President’s ⁢Chancellery, after Karol Nawrocki signed the Act on January 9 of this year – “The changes introduced in the heating allowance Act…

Inflation Reduction‍ Act Lowers Prescription Drug Costs

The Inflation Reduction Act of ⁣2022 (IRA) significantly altered the landscape of prescription‌ drug pricing in the​ United States, allowing Medicare to​ negotiate prices for certain high-expenditure drugs and capping out-of-pocket costs for beneficiaries. This ⁢legislation, signed into law on August 16, 2022, represents the most substantial effort to control drug prices in decades.

Medicare Drug Price⁤ Negotiation

The⁤ Inflation ‍Reduction Act empowers Medicare to directly negotiate the prices of certain prescription drugs with pharmaceutical companies, starting in 2026. This⁣ negotiation process aims to lower costs for both Medicare and its beneficiaries.

Prior to the IRA, Medicare was largely prohibited from negotiating drug prices,⁤ unlike many other ‍developed countries. the‍ new law phases in negotiations over time, beginning with 10 drugs in 2026, increasing to 15 drugs in 2027, and 20 drugs by 2029. Drugs eligible for negotiation must be single-source brand-name drugs without generic or⁢ biosimilar competition. The Centers for Medicare & Medicaid Services⁤ (CMS) released guidance​ on the negotiation process in February 2023.

Example: The⁢ first 10 drugs selected for ⁤negotiation, announced in August 2023, include medications for diabetes, heart failure, and blood ⁣clots, potentially impacting millions of ⁢seniors. CMS’s announcement details the specific drugs and their potential cost savings.

Pharmaceutical Company Responses

Pharmaceutical companies, represented by organizations like the Pharmaceutical Research and⁤ Manufacturers of America (PhRMA), have ​largely opposed the drug ⁣price negotiation provisions, arguing they will stifle innovation.PhRMA has filed lawsuits challenging the constitutionality of the‌ negotiation process, claiming it violates the Fifth Amendment’s takings clause. ‌ Reuters reported on these⁤ legal challenges in July 2023.

Out-of-Pocket Cost Caps for‍ Medicare Beneficiaries

The IRA introduces a $2,000 annual⁤ out-of-pocket cap on prescription drug costs ‌for Medicare part D beneficiaries, beginning in 2025. This cap applies to covered drugs and provides important ‌financial relief for individuals with high ‌medication expenses.

Before the IRA, Medicare beneficiaries⁣ faced potentially unlimited out-of-pocket costs for prescription ⁢drugs. the $2,000 cap, combined with other provisions like eliminating the “donut hole” (coverage gap), aims⁤ to make prescription drugs more affordable and accessible. The Kaiser Family Foundation provides detailed analysis of the Part D changes.

Example: A ‍Medicare beneficiary with cancer requiring expensive chemotherapy drugs could previously face tens of thousands⁣ of dollars in out-of-pocket costs. Under the IRA, their ⁢costs will be limited to $2,000 annually, starting in 2025.

Impact on Insulin Costs

The IRA also includes a provision capping the monthly cost of insulin ⁣at $35 for Medicare beneficiaries, effective ⁣January 1, ​2023.This measure⁤ specifically addresses the rising cost of insulin, ⁢a life-saving medication for millions‌ with diabetes.CMS⁤ details the insulin cost cap and its implementation.

Broader economic Impact and Future Considerations

The Congressional Budget Office (CBO) ‌estimates that ⁤the IRA will reduce the federal deficit by $264 billion over ten years. However,the CBO also⁢ projects that the drug price negotiation provisions will lead‌ to a decrease in pharmaceutical research and advancement spending. The CBO’s report provides a extensive analysis of the IRA’s budgetary ‍effects.

The long-term effects of the IRA on drug innovation⁤ and access remain to be seen. Ongoing monitoring and evaluation will be‌ crucial to assess the law’s impact and make necessary ‌adjustments. The Food and Drug Management (FDA) will play a key role in overseeing the implementation of the IRA and ensuring the continued availability of safe and effective medications.

, , , , , , , ,